CAR Generation for Engineered γδ T lymphocyte

CAR-modified T cell immunotherapy is the most promising approach for cancer treatment in which T cells (such as γδ T cells) are driven to recognize tumor antigens and kill tumor cells. Compared to other therapies such as chemotherapy, CAR-T cell immunotherapy is more specific and less toxic to patients. CAR-modified T cells have shown to significantly eliminate a variety of tumors. Therefore, it is necessary to develop personal CAR-modified T cells for tumor treatment. CAR Generation for Engineered γδ T lymphocyte

Recent reports have shown that the development of CAR TCR-engineered γδ T cells is a promising method in cellular immunotherapy for the treatment of cancer. However, determining the specific function of engineered γδ T cells also plays an important role in cell development. As a professional CRO company in cell therapy, Creative Biolabs provides customized CAR γδ T cell functional test services to meet our clients’ requirements. CAR γδ T lymphocyte Functional Test